About Babson Diagnostics
Babson Diagnostics is a company based in Austin (United States) founded in 2017 by Eric Olson. Babson Diagnostics has raised $37.7 million across 2 funding rounds from investors including Siemens Healthineers, Emerald and Prism Venture Partners. Babson Diagnostics offers products and services including BetterWay Blood Testing. Babson Diagnostics operates in a competitive market with competitors including Tasso, YourBio Health, Velano Vascular, Weavr Health and Lo Biosciences, among others.
- Headquarter Austin, United States
- Founders Eric Olson
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$37.7 M (USD)
in 2 rounds
-
Latest Funding Round
$31 M (USD), Series B
Jun 29, 2021
-
Investors
Siemens Healthineers
& 4 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Babson Diagnostics
Babson Diagnostics offers a comprehensive portfolio of products and services, including BetterWay Blood Testing.
Offers convenient blood testing with minimal sample for accurate results.
People of Babson Diagnostics
Unlock access to complete
Unlock access to complete
Funding Insights of Babson Diagnostics
Babson Diagnostics has successfully raised a total of $37.7M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $31 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Babson Diagnostics
Babson Diagnostics has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Siemens Healthineers, Emerald and Prism Venture Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage venture capital investments are provided by Emerald.
|
Locked | Locked | Locked | |
|
VC firm investing in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Babson Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Babson Diagnostics
Investment portfolio details for Babson Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Babson Diagnostics
Detailed financials for Babson Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Babson Diagnostics Comparisons
Peer comparison for Babson Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Babson Diagnostics
Babson Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Tasso, YourBio Health, Velano Vascular, Weavr Health and Lo Biosciences, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Blood collection devices for diagnostic applications are developed.
|
|
| Locked | Locked | Locked |
Push-button blood collection devices are manufactured for medical use.
|
|
| Locked | Locked | Locked |
Provider of a needle-free blood collection device
|
|
| Locked | Locked | Locked |
Manufactures high-quality blood collection devices for medical applications.
|
|
| Locked | Locked | Locked |
Developer of blood collection device
|
Detailed competitors of Babson Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Babson Diagnostics
Complete news archive for Babson Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Babson Diagnostics
Babson Diagnostics was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Babson Diagnostics is headquartered in Austin, United States. It is registered at Austin, Texas, United States.
David Stein is the current CEO of Babson Diagnostics.
Babson Diagnostics is a funded company, having raised a total of $37.7M across 2 funding rounds to date.
Provider of blood testing service using microsamples collected from a finger. It offers blood testing services, utilizing small blood samples obtained via finger-prick, aiming to make diagnostic testing more accessible. The offering focuses on delivering medically accurate results through a patient-centric approach. The goal is to facilitate regular diagnostic blood testing for early disease detection and informed healthcare decisions.
Babson Diagnostics's top competitors include YourBio Health, Tasso and Velano Vascular.
Babson Diagnostics offers BetterWay Blood Testing.
Babson Diagnostics has 5 investors. Key investors include Siemens Healthineers, Emerald, Prism Venture Partners, LAGO Consulting & Services, and Genesis Merchant Capital.